Tobacco smoking and the risk of heart failure: A systematic review and meta-analysis of prospective studies

Abstract

Background

We conducted a systematic review and meta-analysis to clarify the association between smoking and the risk of developing heart failure.

Methods

PubMed and Embase databases were searched up to 24 July 2018. Prospective studies were included if they reported adjusted relative risk (RR) estimates and 95% confidence intervals (CIs) of heart failure associated with smoking. Summary RRs and 95% CIs were estimated using a random effects model.

Results

Twenty-six studies were included. The summary RR was 1.75 (95% CI: 1.54–1.99, I²= 81%, n = 10) for current smokers, 1.16 (95% CI: 1.08–1.24, I²= 51%, n = 9) for former smokers, and 1.44 (1.34–1.55, I²= 83%, n = 10) for ever smokers compared with never smokers. The summary RR was 1.41 (95% CI: 1.01–1.96, I²= 82%, n = 2) per 10 cigarettes per day, 1.11 (95% CI: 1.04–1.18, I²= 70%, n = 3) and 1.08 (95% CI: 1.02–1.14, I²= 34%, n = 2) per 10 pack-years among ever smokers and former smokers, respectively, and 0.79 (95% CI: 0.63–1.00, I²= 96%, n = 2) per 10 years since quitting smoking. The association between smoking cessation and heart failure reached significance at 15 years of smoking cessation, and at 30 years the summary RR was 0.72 (95% CI: 0.57–0.90), only slightly higher than the summary RR for never smokers (0.64 (95% CI: 0.57–0.72)) when compared with current smokers.

Conclusion

Smoking is associated with increased risk of heart failure, but the risk decreases with increasing duration since smoking cessation. Any further studies should investigate the association between number of cigarettes per day, duration, pack-years and time since quitting smoking and risk of heart failure.

Keywords

Tobacco smoking cigarettes cessation heart failure prospective studies review meta-analysis

Get full access to this article

View all access options for this article.

References

GBD 2015 Mortality and Causes of Death Collaborators. Global, regional, and national life expectancy, all-cause mortality, and cause-specific mortality for 249 causes of death, 1980–2015: A systematic analysis for the Global Burden of Disease Study 2015. Lancet 2016; 388(10053): 1459–1544.

Massie

Shah

. Evolving trends in the epidemiologic factors of heart failure: Rationale for preventive strategies and comprehensive disease management. Am Heart J 1997; 133(6): 703–712.

Shahar

Lee

Kim

et al.

Hospitalized heart failure: Rates and long-term mortality. J Card Fail 2004; 10(5): 374–379.

Spencer

Meyer

Goldberg

et al.

Twenty year trends (1975–1995) in the incidence, in-hospital and long-term death rates associated with heart failure complicating acute myocardial infarction: A community-wide perspective. J Am Coll Cardiol 1999; 34(5): 1378–1387.

Aune

Sen

Norat

et al.

Body mass index, abdominal fatness and heart failure incidence and mortality: A systematic review and dose-response meta-analysis of prospective studies. Circulation 2016; 133(7): 639–649.

Aune

Sen

O’Hartaigh

et al.

Resting heart rate and the risk of cardiovascular disease, total cancer, and all-cause mortality – a systematic review and dose-response meta-analysis of prospective studies. Nutr Metab Cardiovasc Dis 2017; 27(6): 504–517.

Pirie

Peto

Reeves

et al.

The 21st century hazards of smoking and benefits of stopping: A prospective study of one million women in the UK. Lancet 2013; 381(9861): 133–141.

GBD 2015 Tobacco Collaborators . Smoking prevalence and attributable disease burden in 195 countries and territories, 1990–2015: A systematic analysis from the Global Burden of Disease Study 2015. Lancet 2017; 389(10082): 1885–1906.

Eriksson

Svardsudd

Larsson

et al.

Risk factors for heart failure in the general population: The study of men born in 1913. Eur Heart J 1989; 10(7): 647–656.

10.

Alexander

Grumbach

Selby

et al.

Hospitalization for congestive heart failure. Explaining racial differences. JAMA 1995; 274(13): 1037–1042.

11.

Wilhelmsen

Rosengren

Eriksson

et al.

Heart failure in the general population of men – morbidity, risk factors and prognosis. J Intern Med 2001; 249(3): 253–261.

12.

Ogden

Bazzano

et al.

Risk factors for congestive heart failure in US men and women: NHANES I epidemiologic follow-up study. Arch Intern Med 2001; 161(7): 996–1002.

13.

Ingelsson

Sundstrom

Arnlov

et al.

Insulin resistance and risk of congestive heart failure. JAMA 2005; 294(3): 334–341.

14.

Thrainsdottir

Aspelund

Gudnason

et al.

Increasing glucose levels and BMI predict future heart failure experience from the Reykjavik Study. Eur J Heart Fail 2007; 9(10): 1051–1057.

15.

Butler

Kalogeropoulos

Georgiopoulou

et al.

Incident heart failure prediction in the elderly: The health ABC heart failure score. Circ Heart Fail 2008; 1(2): 125–133.

16.

Nichols

Koro

Kolatkar

. The incidence of heart failure among nondiabetic patients with and without impaired fasting glucose. J Diabetes Complications 2009; 23(3): 224–228.

17.

Kalogeropoulos

Georgiopoulou

Kritchevsky

et al.

Epidemiology of incident heart failure in a contemporary elderly cohort: The health, aging, and body composition study. Arch Intern Med 2009; 169(7): 708–715.

18.

Wang

Tuomilehto

Jousilahti

et al.

Lifestyle factors in relation to heart failure among Finnish men and women. Circ Heart Fail 2011; 4(5): 607–612.

19.

Gopal

Kalogeropoulos

Georgiopoulou

et al.

Cigarette smoking exposure and heart failure risk in older adults: The Health, Aging, and Body Composition Study. Am Heart J 2012; 164(2): 236–242.

20.

Lyass

Lee

et al.

Predictors of new-onset heart failure: Differences in preserved versus reduced ejection fraction. Circ Heart Fail 2013; 6(2): 279–286.

21.

de Simone

Devereux

Roman

et al.

Does cardiovascular phenotype explain the association between diabetes and incident heart failure? The Strong Heart Study. Nutr Metab Cardiovasc Dis 2013; 23(4): 285–291.

22.

Agha

Loucks

Tinker

et al.

Healthy lifestyle and decreasing risk of heart failure in women: The Women’s Health Initiative observational study. J Am Coll Cardiol 2014; 64(17): 1777–1785.

23.

Pujades-Rodriguez

George

Shah

et al.

Heterogeneous associations between smoking and a wide range of initial presentations of cardiovascular disease in 1937360 people in England: Lifetime risks and implications for risk prediction. Int J Epidemiol 2015; 44(1): 129–141.

24.

Chahal

Bluemke

et al.

Heart failure risk prediction in the Multi-Ethnic Study of Atherosclerosis. Heart 2015; 101(1): 58–64.

25.

Del Gobbo

Kalantarian

Imamura

et al.

Contribution of major lifestyle risk factors for incident heart failure in older adults: The Cardiovascular Health Study. JACC Heart Fail 2015; 3(7): 520–528.

26.

Tran

Falster

Douglas

et al.

Smoking and potentially preventable hospitalisation: The benefit of smoking cessation in older ages. Drug Alcohol Depend 2015; 150: 85–91.

27.

Zhu

Villeneuve

et al.

Chronic disease prevalence in women and air pollution – a 30-year longitudinal cohort study. Environ Int 2015; 80: 26–32.

28.

Ahmed

Patel

Nyaku

et al.

Risk of heart failure and death after prolonged smoking cessation: Role of amount and duration of prior smoking. Circ Heart Fail 2015; 8(4): 694–701.

29.

Eaton

Pettinger

Rossouw

et al.

Risk factors for incident hospitalized heart failure with preserved versus reduced ejection fraction in a multiracial cohort of postmenopausal women. Circ Heart Fail 2016; 9(10): e002883–e002883.

30.

Larsson

Tektonidis

Gigante

et al.

Healthy lifestyle and risk of heart failure: Results from 2 prospective cohort studies. Circ Heart Fail 2016; 9(4): e002855–e002855.

31.

Jacobs

Efremov

Ferreira

et al.

Risk for incident heart failure: A subject-level meta-analysis from the Heart ‘OMics’ in AGEing (HOMAGE) Study. J Am Heart Assoc 2017; 6(5): e005231–e005231.

32.

Jackson

Safo

Staimez

et al.

Reduced cardiovascular disease incidence with a national lifestyle change program. Am J Prev Med 2017; 52(4): 459–468.

33.

Spahillari

Talegawkar

Correa

et al.

Ideal cardiovascular health, cardiovascular remodeling, and heart failure in blacks: The Jackson Heart Study. Circ Heart Fail 2017; 10(2): e003682–e003682.

34.

Ogunmoroti

Oni

Michos

et al.

Life’s Simple 7 and incident heart failure: The Multi-Ethnic Study of Atherosclerosis. J Am Heart Assoc 2017; 6(6): e005180–e005180.

35.

Kamimura

Cain

Mentz

et al.

Cigarette smoking and incident heart failure: Insights from the Jackson Heart Study. Circulation 2018; 137(24): 2572–2582.

36.

Abramson

Williams

Krumholz

et al.

Moderate alcohol consumption and risk of heart failure among older persons. JAMA 2001; 285(15): 1971–1977.

37.

Brouwers

de Boer

Van der

et al.

Incidence and epidemiology of new onset heart failure with preserved vs. reduced ejection fraction in a community-based cohort: 11-year follow-up of PREVEND. Eur Heart J 2013; 34(19): 1424–1431.

38.

Stroup

Berlin

Morton

et al.

Meta-analysis of observational studies in epidemiology: A proposal for reporting. Meta-analysis Of Observational Studies in Epidemiology (MOOSE) group. JAMA 2000; 283(15): 2008–2012.

39.

DerSimonian

Laird

. Meta-analysis in clinical trials. Control Clin Trials 1986; 7(3): 177–188.

40.

Greenland

Longnecker

. Methods for trend estimation from summarized dose-response data, with applications to meta-analysis. Am J Epidemiol 1992; 135(11): 1301–1309.

41.

Jackson

White

Thompson

. Extending DerSimonian and Laird’s methodology to perform multivariate random effects meta-analyses. Stat Med 2010; 29(12): 1282–1297.

42.

Orsini

Wolk

et al.

Meta-analysis for linear and nonlinear dose-response relations: Examples, an evaluation of approximations, and software. Am J Epidemiol 2012; 175(1): 66–73.

43.

Higgins

Thompson

. Quantifying heterogeneity in a meta-analysis. Stat Med 2002; 21(11): 1539–1558.

44.

Wells G, Shea B, O’Connell D., et al. The Newcastle-Ottawa Scale (NOS) for assessing the quality of nonrandomised studies in meta-analyses, www.ohri.ca/programs/clinical_epidemiology/oxford.asp (2013, accessed 9 August 2018).

45.

Egger

Davey

Schneider

et al.

Bias in meta-analysis detected by a simple, graphical test. BMJ 1997; 315(7109): 629–634.

46.

Begg

Mazumdar

. Operating characteristics of a rank correlation test for publication bias. Biometrics 1994; 50(4): 1088–1101.

47.

Yeh

Levasseur

Kaiserman

. Evaluation of urinary cotinine immunoassay test strips used to assess smoking status. Nicotine Tob Res 2011; 13(11): 1045–1051.

48.

Kim

Jung

. Optimum cutoff value of urinary cotinine distinguishing South Korean adult smokers from nonsmokers using data from the KNHANES (2008–2010). Nicotine Tob Res 2013; 15(9): 1608–1616.

49.

Studts

Ghate

Gill

et al.

Validity of self-reported smoking status among participants in a lung cancer screening trial. Cancer Epidemiol Biomarkers Prev 2006; 15(10): 1825–1828.

50.

Vidyasagaran

Siddiqi

Kanaan

. Use of smokeless tobacco and risk of cardiovascular disease: A systematic review and meta-analysis. Eur J Prev Cardiol 2016; 23(18): 1970–1981.

51.

Pan

Wang

Talaei

et al.

Relation of active, passive, and quitting smoking with incident type 2 diabetes: A systematic review and meta-analysis. Lancet Diabetes Endocrinol 2015; 3(12): 958–967.

52.

Bowman

Gaziano

Buring

et al.

A prospective study of cigarette smoking and risk of incident hypertension in women. J Am Coll Cardiol 2007; 50(21): 2085–2092.

53.

Halperin

Gaziano

Sesso

. Smoking and the risk of incident hypertension in middle-aged and older men. Am J Hypertens 2008; 21(2): 148–152.

54.

Dochi

Sakata

Oishi

et al.

Smoking as an independent risk factor for hypertension: A 14-year longitudinal study in male Japanese workers. Tohoku J Exp Med 2009; 217(1): 37–43.

55.

Zhu

Yuan

Shen

et al.

Association of smoking with the risk of incident atrial fibrillation: A meta-analysis of prospective studies. Int J Cardiol 2016; 218: 259–266.

56.

Linneberg

Jacobsen

Skaaby

et al.

Effect of smoking on blood pressure and resting heart rate: A Mendelian randomization meta-analysis in the CARTA Consortium. Circ Cardiovasc Genet 2015; 8(6): 832–841.

57.

Minicucci

Azevedo

Polegato

et al.

Cardiac remodeling induced by smoking: Concepts, relevance, and potential mechanisms. Inflamm Allergy Drug Targets 2012; 11(6): 442–447.

58.

Rosen

Saad

Shea

et al.

Hypertension and smoking are associated with reduced regional left ventricular function in asymptomatic: individuals the Multi-Ethnic Study of Atherosclerosis. J Am Coll Cardiol 2006; 47(6): 1150–1158.

59.

Salahuddin

Prabhakaran

Roy

. Pathophysiological mechanisms of tobacco-related CVD. Glob Heart 2012; 7(2): 113–120.

60.

Nadruz

Jr Claggett

Goncalves

et al.

Smoking and cardiac structure and function in the elderly: The ARIC Study (Atherosclerosis Risk in Communities). Circ Cardiovasc Imaging 2016; 9(9): e004950–e004950.

61.

Otsuka

Kawada

Seino

et al.

Relation of smoking status to serum levels of N-terminal pro-brain natriuretic peptide in middle-aged men without overt cardiovascular disease. Am J Cardiol 2010; 106(10): 1456–1460.

62.

Nadruz

Jr Goncalves

Claggett

et al.

Influence of cigarette smoking on cardiac biomarkers: The Atherosclerosis Risk in Communities (ARIC) Study. Eur J Heart Fail 2016; 18(6): 629–637.

63.

Carter

Abnet

Feskanich

et al.

Smoking and mortality – beyond established causes. N Engl J Med 2015; 372(7): 631–640.

64.

Piepoli

Villani

. Lifestyle modification in secondary prevention. Eur J Prev Cardiol 2017; 24(3_suppl): 101–107.

Supplementary Material

Please find the following supplemental material available below.

For Open Access articles published under a Creative Commons License, all supplemental material carries the same license as the article it is associated with.

For non-Open Access articles published, all supplemental material carries a non-exclusive license, and permission requests for re-use of supplemental material or any part of supplemental material shall be sent directly to the copyright owner as specified in the copyright notice associated with the article.

0.00 MB

0.58 MB